| 國立臺灣大學 |
2016 |
Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma
|
Chen, Yi-Lien; Chiang, Bor-Luen; 江伯倫 |
| 臺大學術典藏 |
2020-06-27T06:39:04Z |
Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma
|
Chen Y.-L.;Bor-Luen Chiang; Chen Y.-L.; BOR-LUEN CHIANG |
| 國家衛生研究院 |
2017-07 |
Targeting tumor associated phosphatidylserine with new zinc dipicolylamine-based drug conjugates
|
Liu, YW;Shia, KS;Wu, CH;Liu, KL;Yeh, YC;Lo, CF;Chen, CT;Chen, YY;Yeh, TK;Chen, WH;Jan, JJ;Huang, YC;Huang, CL;Fang, MY;Gray, BD;Pak, KY;Hsu, TA;Huang, KH;Tsou, LK |
| 臺大學術典藏 |
2020-12-02T02:33:13Z |
Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered Virotherapy
|
Tseng S.-J.;Kempson I.M.;Huang K.-Y.;Li H.-J.;Fa Y.-C.;Ho Y.-C.;Liao Z.-X.;Pan-Chyr Yang; Tseng S.-J.; Kempson I.M.; Huang K.-Y.; Li H.-J.; Fa Y.-C.; Ho Y.-C.; Liao Z.-X.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-02-25T04:02:59Z |
Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered Virotherapy
|
Sj Tseng;Kempson I.M.;Huang K.-Y.;Li H.-J.;Fa Y.-C.;Ho Y.-C.;Liao Z.-X.;Yang P.-C.; SJ TSENG; Kempson I.M.; Huang K.-Y.; Li H.-J.; Fa Y.-C.; Ho Y.-C.; Liao Z.-X.; Yang P.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:11Z |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Cheng A.-L.; CHIH-HUNG HSU; Liang C.-W.; Chang C.-J.;Yang Y.-H.;Chiu C.-J.;Lu L.-C.;Liao C.-C.;Liang C.-W.;Chih-Hung Hsu;Cheng A.-L.; Chang C.-J.; Yang Y.-H.; Chiu C.-J.; Lu L.-C.; Liao C.-C. |
| 臺大學術典藏 |
2021-03-15T07:44:44Z |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang C.-J.;Yang Y.-H.;Chiu C.-J.;Li-Chun Lu;Liao C.-C.;Liang C.-W.;Hsu C.-H.;Cheng A.-L.; Chang C.-J.; Yang Y.-H.; Chiu C.-J.; LI-CHUN LU; Liao C.-C.; Liang C.-W.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2018 |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang C.-J.;Yao-Hsu Yang;Chiu C.-J.;Lu L.-C.;Liao C.-C.;Liang C.-W.;Hsu C.-H.;Cheng A.-L.; Chang C.-J.; YAO-HSU YANG; Chiu C.-J.; Lu L.-C.; Liao C.-C.; Liang C.-W.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:29:29Z |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang C.-J.; Yang Y.-H.; Chiu C.-J.; Lu L.-C.; Liao C.-C.; Liang C.-W.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T18:06:23Z |
Targeting tumor-infiltrating Ly6G+myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang, C.-J.;Yang, Y.-H.;Chiu, C.-J.;Lu, L.-C.;Liao, C.-C.;Liang, C.-W.;Hsu, C.-H.;Cheng, A.-L.; ANN-LII CHENG |
